CTOs on the Move

American Clinical Laboratories

www.amclabs.com

 
American Clinical Laboratories is a Tucker, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.amclabs.com
  • 4727 N Royal Atlanta Dr Ste D
    Tucker, GA USA 30084
  • Phone: 770.414.9000

Executives

Name Title Contact Details

Similar Companies

Northeast Orthpaedics

Northeast Orthpaedics is a Concord, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Roca Labs Pharmaceuticals

Roca Labs Pharmaceuticals is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProLung Incorporated

ProLung`s mission is to make a difference in time for lung cancer patients. ProLung is a leader in innovative predictive analytics technology and non-invasive biomarkers for the risk stratification of lung cancer. The Company develops, tests, and commercializes solutions which may shorten the time to diagnosis and expand the therapeutic window for lung cancer patients.

LifeLogics

LifeLogics is a Halethorpe, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gritstone Oncology

Gritstone Oncology is a privately-held company headquartered in the San Francisco Bay Area with key functions located in Cambridge, Massachusetts and Pleasanton, California. We launched in October 2015, and since inception, have successfully raised two large, private financing rounds. We currently employ more than 60 professionals. We have brought together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to tackle fundamental challenges at the intersection of cancer genomics and immunotherapy. With our unique approach to immuno-oncology, we are developing next-generation personalized immunotherapies to fight cancer in patients with the most difficult-to-treat tumors. We plan to combine these personalized neoantigen-targeted therapies with current immune checkpoint modulatory approaches to improve response rates and survival in patients with solid tumors.